Clean EBIT SEK 49m vs. ABGSCe SEK -28m Q4 likely weaker than Q3 Conference call at 12 CET Clean EBI...
En av Sveriges största uthyrningar är nu i hamn. I början av augusti meddelade Fabege att det har in...
ARR i linje med tidigare guidning från Q2 Omsättningen i kvartalet uppgick till 36,0 mkr, vilket mot...
Alisa Bank’s equity story took a hit from challenges relating to strengthening of the capital struct...
CapMan's net sales in Q3 amounted to EUR 13.7m, below our estimates and below consensus (EUR 17.
SRV's net sales in Q3 amounted to EUR 146.9m, only slightly below our estimate of EUR 151.
Solteq’s Q3 results were as expected rather weak but revenue turned to growth in comparable terms an...
Redeye is happy to see that Railcare has been awarded another major long-term contract by the Swedis...
Redeye provides its initial take on Mentice’s Q3 2023 report, which featured stronger top-line growt...
Fiskars’ Q3 adjusted EBIT of EUR 17.9m came slightly above preliminary figures released on 12 Octobe...
ARR +9% y-o-y, in line with ABGSCe Outlook unchanged despite a tougher market Cons.
Q3 well above our expectations, mainly on margins Weak CF driven by WC tie-up Share is trading at 5.
Redeye comments on Carasent's Q3 2023 report, which was heavily influenced by lower consulting reven...
Redeye provides a short comment on this morning’s Q3 report from Ortoma.
Sales +2% and adj. EBITDA +16% vs. ABGSCe Operating cash flow 100% above ABGSCe Restructuring effort...
Redeye provides its initial comment on BONESUPPORT’s Q3 report.
NOI +0% and rec PTP +3% vs ABGSCe EC IFPM +33% q-o-q and +2% vs ABGSC 2024e Net LTV down to 27.
Förvaltningsresultat ökade med 14% på årsbasis och substansvärdet uppgick till 211 kronor.
Redeye provides its initial take on ADDvise’s Q3 2023 report, which came in broadly above our estima...
Redeye provides its initial comment on Sedana Medical’s Q3 report.
